Você procurou por: herpetiform skin eruptions (Inglês - Maltês)

itching, rash (skin eruptions)
Ħakk, raxx (erruzjonjiet tal-ġilda)

skin eruptions, skin cracking, flaking or peeling skin
eruzzjonijiet tal-ġilda, qsim tal-ġilda, il-ġilda li tinqala’ jew titqaxxar

- multiple skin eruptions (erythema multiforme minor)
- eruzzjonijiet multipli fil- ġilda (erythema multiformi minuri)

ppe is characterised by painful, macular reddening skin eruptions.
il-ppe hija kkaratteriżżata minn msiemer li jweġġgħu bi dbajja' ħomor fil-ġilda.

allergic reactions including urticaria, mild skin eruptions, bronchospasm and angioedema
reazzjonijiet allerġiċi li jinkludu urtikarja, tfaċċar f’ daqqa waħda ta ’ msiemer fil- ġilda tat- tip moderat, bronkospażmu u anġjodema

toxic skin eruption
eruzzjoni tossika tal-ġilda

toxic skin eruption rash
infafet tossiċi tal-ġilda raxx

very rare • severe skin reactions, including desquamation and bullous skin eruptions musculoskeletal and connective tissue disorders
rari ħafna • reazzjonijiet severi fuq il- ġilda li jinkludu deskwamazzjoni u eruzzjonijiet bullożi fuq il- ġilda disturbi muskolu- skeltrali u tal- connective tissue

toxic skin eruption rash dry skin
infafet tossiċi tal- ġilda raxx Ġilda xotta

- various skin eruptions or rashes (e.g. the potentially fatal stevens-johnson syndrome or toxic
- diversi eruzzjonijiet jew raxx fil- ġilda (e. ż. s- sindrome stevens- johnson li tista ’ tkun fatali jew

rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first 3 weeks of starting therapy with atazanavir.
normalment, ir-raxxijiet huma eruzzjonijiet tal-ġilda makulopapulari ħfief għal moderati li jseħħu fi żmien l-ewwel 3 ġimgħat minn meta tinbeda l-kura b’atazanavir.

nail disorder (changes to the nail such as ridges and/or splitting) multiple skin eruptions (erythema multiforme).
disturb fid-dwiefer (bidliet fid-dwiefer bħal xfarijiet u/jew qsim) ħafna ponot fil-ġilda (erythema multiforme).

rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first 3 weeks of starting therapy with atazanavir, a component of evotaz.
normalment, ir-raxxijiet huma eruzzjonijiet tal-ġilda makulopapulari ħfief għal moderati li jseħħu fi żmien l-ewwel 3 ġimgħat minn meta tinbeda l-kura b’atazanavir, komponent ta’ evotaz.

skin allergies such as rash with or without paleness, redness, patches, severe itching; and skin eruptions such as welts or hives have also been reported after receiving neurobloc.
allerġiji tal-ġilda bħal raxx bi jew mingħajr sfura, ħmura, irqajja’, ħakk sever; u eruzzjonijiet tal-ġilda bħal welts jew urtikarja kienu rrappurtati wkoll wara li pazjent ikun ingħata neurobloc.

allergic reactions including angioneurotic oedema, skin eruption, urticaria and pruritus.
reazzjonijiet allerġiċi li jinkludu edema anġjonewrotika, eruzzjoni fil-ġilda, urtikarja u ħakk.

rash: in clinical trials of efavirenz, rashes were usually mild-to-moderate maculopapular skin eruptions that occurred within the first two weeks of initiating therapy with efavirenz.
raxx: fi studji kliniċi ta' efavirenz, ir-raxxijiet kienu ġeneralment eruzzjonijiet tal-ġilda makulopapulari ħfief għal moderati li seħħew fi żmien l-ewwel ġimagħtejn li tinbeda terapija b’efavirenz.

if symptoms appear after exposition as a skin eruption, a doctor should be consulted showing these warnings.
jekk jidhru sintomi wara l- esponiment bħala eruzzjoni tal- ġilda, għandu jiġi kkonsultat tabib u dawn it- twissijiet jintwerewlu.

angioedema (with fatal outcome), drug eruption, toxic skin eruption, urticaria
anġjoedema (b’riżultat fatali), eruzzjoni minħabba l-mediċina, eruzzjoni tossika tal-ġilda, urtikarja

skin redness, an itchy rash with raised yellow or white lumps that are surrounded by red inflammation, skin eruption, allergic reactions.
Ħmura tal-ġilda, raxx bil-ħakk b’infafet sofor jew bojod li huma mdawwra b’infjammazzjoni ħamra, imsiemer, reazzjonijiet allerġiċi.

angioedema (also with fatal outcome), eczema, erythema, , urticaria, drug eruption, toxic skin eruption
anġjoedema (ukoll b’riżultat fatali), ekżema, eritema, urtikarja, eruzzjoni minħabba l-mediċina, eruzzjoni tossika tal-ġilda